Literature DB >> 21943840

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

V Vella1, V Racalbuto, R Guerra, C Marra, A Moll, Z Mhlanga, M Maluleke, H Mhlope, B Margot, G Friedland, N S Shah, N R Gandhi.   

Abstract

SETTING: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are now a nationwide epidemic in South Africa. Epidemiological data suggest nosocomial transmission as the primary route of spread; however, transmission among household contacts has not yet been investigated.
OBJECTIVE: To determine the incidence rates of MDR- and XDR-TB among household contacts of MDR- and XDR-TB index cases diagnosed between January 2005 and September 2008 in a high human immunodeficiency virus prevalence setting.
DESIGN: Prospective, observational study evaluating adult household contacts for active TB by culture and drug susceptibility testing at index case diagnosis and again 1 year later. Outcomes were incidence and time to diagnosis of MDR- and XDR-TB.
RESULTS: A total of 1766 contacts of 221 MDR-TB and 287 XDR-TB index cases were screened. Of 793 contacts of MDR-TB index cases, 14 (1.8%) were diagnosed with MDR-TB (incidence 1765/100 000); 19 (2.0%) of 973 XDR-TB contacts had XDR-TB (incidence 1952/100 000). Median time to diagnosis of household cases was 70 days (interquartile range 57-89).
CONCLUSION: Incidence rates of MDR- and XDR-TB among household contacts were extremely high, with most secondary cases occurring shortly after the diagnosis of the index case. Active case finding of drug-resistant TB is a high-yield public health activity and must be a priority, as early diagnosis may stem further disease spread and improve survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21943840     DOI: 10.5588/ijtld.10.0781

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  24 in total

1.  Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa.

Authors:  Adrienne E Shapiro; Ebrahim Variava; Modiehi H Rakgokong; Neshen Moodley; Binnu Luke; Saeed Salimi; Richard E Chaisson; Jonathan E Golub; Neil A Martinson
Journal:  Am J Respir Crit Care Med       Date:  2012-03-15       Impact factor: 21.405

2.  Six degrees of separation: use of social network analysis to better understand outbreaks of nosocomial transmission of extensively drug-resistant tuberculosis.

Authors:  Ashwin S Dharmadhikari
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

3.  Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

Authors:  Amita Gupta; Susan Swindells; Soyeon Kim; Michael D Hughes; Linda Naini; Xingye Wu; Rodney Dawson; Vidya Mave; Jorge Sanchez; Alberto Mendoza; Pedro Gonzales; Nagalingeswaran Kumarasamy; Kyla Comins; Francesca Conradie; Justin Shenje; Sandy Nerette Fontain; Anthony Garcia-Prats; Aida Asmelash; Supalert Nedsuwan; Lerato Mohapi; Umesh G Lalloo; Ana Cristina Garcia Ferreira; Christopher Mugah; Mark Harrington; Lynne Jones; Samyra R Cox; Betsy Smith; N Sarita Shah; Anneke C Hesseling; Gavin Churchyard
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 4.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

Review 5.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

Review 6.  Transmission of tuberculosis in resource-limited settings.

Authors:  Tejaswi Kompala; Sheela V Shenoi; Gerald Friedland
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

Review 7.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

Review 8.  Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.

Authors:  E L Corbett; P MacPherson
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

9.  Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.

Authors:  S Bamrah; R Brostrom; F Dorina; L Setik; R Song; L M Kawamura; A Heetderks; S Mase
Journal:  Int J Tuberc Lung Dis       Date:  2014-08       Impact factor: 2.373

10.  Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.

Authors:  Beauty Makamure; Jesca Mhaka; Salome Makumbirofa; Reggie Mutetwa; Lucy Mupfumi; Peter Mason; John Z Metcalfe
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.